New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
Saved in:
Main Authors: | Filippos Panteleimon Chatzipieris, Athanasios Kokkalis, Nikitas Georgiou, Errikos Petsas, Ektoras Vasileios Apostolou, Georgios C. Vougioukalakis, Thomas Mavromoustakos |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2025-06-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.5c00134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease
by: Ayesha Asim, et al.
Published: (2025-07-01) -
Autoantibody profiling of autism spectrum disorder patients with monoamine oxidase a deficiency
by: Guan-Da Syu, et al.
Published: (2025-08-01) -
Intestinal monoamine oxidase activity in premature and full-term infants with surgical pathology
by: P. K. Vinel, et al.
Published: (2025-01-01) -
Coumarin derivatives as inhibitors against monoamine oxidase: structure-activity relationships and inhibitory mechanisms
by: Jie Sun, et al.
Published: (2025-01-01) -
Evaluating the inhibitory efficacy of Oxalis phytocompounds on monoamine oxidase B: An integrated approach targeting age related neurodegenerative diseases through molecular docking and dynamics simulations.
by: Ram Lal Swagat Shrestha, et al.
Published: (2025-01-01)